A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody
- Status
- COMPLETED
- Phase
- PHASE1
The Good Patient Study
- Status
- COMPLETED
- Phase
- N/A
MVX-ONCO-1 in Patients With Solid Tumor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Vascular Dysfunction and Antiangiogenic Therapy
- Status
- COMPLETED
- Phase
- N/A
BGJ398 for Patients With Tumors With FGFR Genetic Alterations
- Status
- TERMINATED
- Phase
- PHASE2
Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4166-001)
- Status
- COMPLETED
- Phase
- PHASE1
Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease
- Status
- WITHDRAWN
- Phase
- PHASE4
A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase 1 TH-302 Mass Balance Trial
- Status
- COMPLETED
- Phase
- PHASE1
Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
- Status
- COMPLETED
- Phase
- N/A
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)
- Status
- TERMINATED
- Phase
- PHASE1
Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
RX-5902 Treatment of Subjects With Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
LGX818 for Patients With BRAFV600 Mutated Tumors
- Status
- TERMINATED
- Phase
- PHASE2